The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date

The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date

Christina Antza,1,* Krishnarajah Nirantharakumar,2,* Ioannis Doundoulakis,3 Abd A Tahrani,4–6 Konstantinos A Toulis2,313rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece; 2Institute of Applied Health Research, University of Birmingham, Bi...

Full description

Bibliographic Details
Main Authors: Antza C, Nirantharakumar K, Doundoulakis I, Tahrani AA, Toulis KA
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Drug Design, Development and Therapy
Subjects:
Glucagon-like peptide
pharmacokinetics
therapeutics
Online Access:https://www.dovepress.com/the-development-of-an-oral-glp-1-receptor-agonist-for-the-management-o-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/the-development-of-an-oral-glp-1-receptor-agonist-for-the-management-o-peer-reviewed-article-DDDT

Similar Items